JACIE Committee

JACIE Committee Team

John Snowden

EBMT Secretary

Scientific Council Representative with Portfolio Registry

Chairperson JACIE Committee

United Kingdom

SEND EMAIL

@JohnASnowden

Nina Worel

Chairperson Donor Outcomes Committee

EBMT Representative to the JACIE Committee

Austria

SEND EMAIL

Franco Bambi

ISCT REPRESENTATIVE TO THE JACIE COMMITTEE

Franco.bambi@meyer.it

Italy

Fermin Sanchez-Guijo Martin JACIE Accreditation

Fermín Sanchez-Guijo

ISCT REPRESENTATIVE TO THE JACIE COMMITTEE

ferminsg@usal.es

Spain

Riccardo Saccardi

JACIE Medical Director

Clinical Accreditation Committee Member

riccardo.saccardi@unifi.it

Italy

Related documents

Download PDF

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE).

Download pdf

EBMT 2019 JACIE Poster

Download pdf

EBMT receives a regulatory qualification from the European Medicine Agency (EMA) on the use of its patient registry to support novel CAR T-cell therapies.

The EBMT registry has been qualified by EMA as a suitable platform for the collection of data for post-authorisation safety surveillance and efficacy studies.

Download pdf

EMA qualification opinion on Cellular therapy module of the EBMT Registry

EBMT requested qualification of the cellular therapy module of the EBMT Registry as suitable for performing pharmacoepidemiological studies for regulatory purposes, concerning CAR-T cell therapy for haematological malignancies.

Download pdf

Letter from NHS England to JACIE

As part of NHS England preparations to deliver CAR-T cell therapies to patients in England, nine centres underwent on-site inspection in Autumn 2018.

Download ocx

Case Submission Form for Corrective and Preventive Actions Session

See more documents